135 related articles for article (PubMed ID: 30786336)
1. [Complications of transperineal template-guided prostate mapping biopsy].
Wang F; Ding XF; Xu JN; Xu YZ; Zhou YQ; Luan Y; Lu SM; Tao HZ
Zhonghua Yi Xue Za Zhi; 2019 Feb; 99(6):428-431. PubMed ID: 30786336
[No Abstract] [Full Text] [Related]
2. Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy.
Tsivian M; Abern MR; Qi P; Polascik TJ
Urology; 2013 Jul; 82(1):166-70. PubMed ID: 23697794
[TBL] [Abstract][Full Text] [Related]
3. [Pelvic MRI combined with TRUS-guided transperineal template mapping biopsy for the diagnosis of prostate cancer].
Li Q; Xie JJ; Cao WZ; Deng JP; Liu C; Cui Y; Shao Q; Shen H
Zhonghua Nan Ke Xue; 2019 May; 25(5):408-413. PubMed ID: 32216225
[TBL] [Abstract][Full Text] [Related]
4. The morbidity of transperineal template-guided prostate mapping biopsy.
Merrick GS; Taubenslag W; Andreini H; Brammer S; Butler WM; Adamovich E; Allen Z; Anderson R; Wallner KE
BJU Int; 2008 Jun; 101(12):1524-9. PubMed ID: 18325064
[TBL] [Abstract][Full Text] [Related]
5. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
6. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.
Michael ZD; Kotamarti S; Deivasigamani S; Seguier D; Polascik TJ
Urology; 2023 Jul; 177():115-121. PubMed ID: 37105359
[TBL] [Abstract][Full Text] [Related]
8. Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.
Bittner N; Merrick G; Taira A; Bennett A; Schattel A; Butler W; Galbreath R; Adamovich E
Am J Clin Oncol; 2018 Aug; 41(8):723-729. PubMed ID: 27906722
[TBL] [Abstract][Full Text] [Related]
9. Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate.
Bittner N; Merrick GS; Stewart R; Andreini H; Taubenslag W; Curtis R; Butler WM; Wallner KE
Urol Oncol; 2011; 29(4):398-404. PubMed ID: 19945303
[TBL] [Abstract][Full Text] [Related]
10. Clinical performance of transperineal template guided mapping biopsy for therapeutic decision making in low risk prostate cancer.
Ahallal Y; Sanchez-Salas R; Sivaraman A; Barret E; Secin FP; Validire P; Rozet F; Galiano M; Cathelineau X
Actas Urol Esp; 2016 Dec; 40(10):615-620. PubMed ID: 27527686
[TBL] [Abstract][Full Text] [Related]
11. Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy.
Lee CU; Sung SH; Jang CT; Kang M; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
Urol Int; 2019; 103(3):262-269. PubMed ID: 31269509
[TBL] [Abstract][Full Text] [Related]
12. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
[TBL] [Abstract][Full Text] [Related]
13. Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.
Merrick GS; Tennant A; Fiano R; Bennett A; Anderson R; Galbreath R; Butler WM; Adamovich E
World J Urol; 2020 Feb; 38(2):361-369. PubMed ID: 31020423
[TBL] [Abstract][Full Text] [Related]
14. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
Ekwueme K; Simpson H; Zakhour H; Parr NJ
BJU Int; 2013 Jun; 111(8):E365-73. PubMed ID: 23714648
[TBL] [Abstract][Full Text] [Related]
15. Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.
Miah S; Eldred-Evans D; Simmons LAM; Shah TT; Kanthabalan A; Arya M; Winkler M; McCartan N; Freeman A; Punwani S; Moore CM; Emberton M; Ahmed HU
J Urol; 2018 Dec; 200(6):1235-1240. PubMed ID: 29940251
[TBL] [Abstract][Full Text] [Related]
16. Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy.
Akbal C; Türker P; Tavukçu HH; Simşek F; Türkeri L
Eur Urol; 2008 Mar; 53(3):540-4. PubMed ID: 17619078
[TBL] [Abstract][Full Text] [Related]
17. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
18. Transperineal template-guided prostate saturation biopsies in men with suspicion of prostate cancer: a pilot study from Pakistan.
Mehmood K; Mubarak M; Dhar M; Rafi M; Kinsella J
Malays J Pathol; 2017 Dec; 39(3):285-288. PubMed ID: 29279591
[TBL] [Abstract][Full Text] [Related]
19. Transperineal template-guided mapping biopsy as a staging procedure to select patients best suited for active surveillance.
Taira AV; Merrick GS; Bennett A; Andreini H; Taubenslag W; Galbreath RW; Butler WM; Bittner N; Adamovich E
Am J Clin Oncol; 2013 Apr; 36(2):116-20. PubMed ID: 22307210
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.
Bittner N; Merrick GS; Bennett A; Butler WM; Andreini HJ; Taubenslag W; Adamovich E
Am J Clin Oncol; 2015 Jun; 38(3):300-3. PubMed ID: 23764680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
